Michael Rocco to Cost-Benefit Analysis
This is a "connection" page, showing publications Michael Rocco has written about Cost-Benefit Analysis.
Connection Strength
0.175
-
Pierce DA, Rocco MV. Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells. Pharmacotherapy. 2010 Nov; 30(11):1150-8.
Score: 0.093
-
Rocco MV. Disease management programs for CKD patients: the potential and pitfalls. Am J Kidney Dis. 2009 Mar; 53(3 Suppl 3):S56-63.
Score: 0.082